Reaction
Pharyngeal Disorder reporting signals
As of the last recalculation, Pharyngeal Disorder appears in 2,848 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED (PRR 13.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 38 | 13.2 | 13.2 |
| Valproate Sodium | 34 | 12.2 | 12.2 |
| Fluticasone Propionate And Salmeterol | 55 | 9.8 | 9.8 |
| Omalizumab | 96 | 8.5 | 8.5 |
| Fluticasone Furoate | 14 | 8.5 | 8.5 |
| Ocrelizumab | 66 | 7.9 | 7.9 |
| Thyroid, Porcine | 10 | 6.9 | 6.9 |
| Felodipine Extended-Release Tablets | 10 | 6.4 | 6.4 |
| Felodipine | 10 | 6.4 | 6.4 |
| Fesoterodine Fumarate | 9 | 6.1 | 6.1 |
| Fluticasone Propionate And Salmeterol Xinafoate | 41 | 5.0 | 5.1 |
| Umeclidinium | 6 | 4.9 | 4.9 |
| Mometasone Furoate And Formoterol Fumarate Dihydrate | 10 | 4.7 | 4.7 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 10 | 4.4 | 4.4 |
| Insulin Glulisine | 6 | 4.3 | 4.3 |
| Fluticasone Furoate And Vilanterol Trifenatate | 21 | 4.3 | 4.3 |
| Nicotine Polacrilex | 20 | 3.8 | 3.8 |
| Vismodegib | 4 | 3.3 | 3.3 |
| Dofetilide | 4 | 2.8 | 2.8 |
| Nirmatrelvir And Ritonavir | 20 | 2.7 | 2.7 |
| Pegvaliase-Pqpz | 3 | 2.7 | 2.7 |
| Varenicline Tartrate | 28 | 2.6 | 2.6 |
| Palbociclib | 31 | 2.4 | 2.4 |
| Botulinum Toxin Type A | 4 | 2.4 | 2.4 |
| Pirfenidone | 13 | 2.3 | 2.3 |
| Axitinib | 6 | 2.3 | 2.3 |
| Peginterferon Alfa-2A | 16 | 2.2 | 2.2 |
| Dimethyl Fumarate | 34 | 2.0 | 2.0 |
| Natalizumab | 46 | 1.9 | 1.9 |
| Onabotulinumtoxina | 17 | 1.6 | 1.6 |
| Droxidopa | 4 | 1.4 | 1.4 |
| Evolocumab | 24 | 1.1 | 1.1 |